| P50 | author | Michael Hoelscher | Q72527439 |
| P2093 | author name string | Thomas Löscher | |
| | Sebastian Kobold | |
| | Andreas Wieser | |
| | Michael Pritsch | |
| | Nicole Berens-Riha | |
| | Sören Schubert | |
| | Michael Chaloupka | |
| | Annabell Peter | |
| | Gabriele Liegl | |
| | Najib Ben-Khaled | |
| P2860 | cites work | Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose | Q64132166 |
| | Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production | Q70338857 |
| | Quantitation of IgG subclass antibody responses after immunization with a group B meningococcal outer membrane vesicle vaccine, using monoclonal mouse-human chimeric antibodies as standards | Q71615040 |
| | Intranasal immunization with liposomes induces strong mucosal immune responses in mice | Q72209858 |
| | Plasmodium falciparum: production and characterization of rat monoclonal antibodies specific for the sexual-stage Pfs48/45 antigen | Q73509627 |
| | Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvant | Q74468301 |
| | CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice | Q74770007 |
| | Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC | Q77715989 |
| | Global malaria mortality between 1980 and 2010: a systematic analysis | Q20905423 |
| | Vaccination greatly reduces disease, disability, death and inequity worldwide | Q24648884 |
| | Assessment of efficacy and safety of pandemic A/H1N1/2009 influenza vaccine in a group of health care workers. | Q30419757 |
| | Recombinant human antibodies specific for the Pfs48/45 protein of the malaria parasite Plasmodium falciparum | Q30984883 |
| | Protection from hemolytic uremic syndrome by eyedrop vaccination with modified enterohemorrhagic E. coli outer membrane vesicles | Q33416476 |
| | A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli | Q33485233 |
| | Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparum | Q33521214 |
| | Delivery of foreign antigens by engineered outer membrane vesicle vaccines | Q33733590 |
| | Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans. | Q33752052 |
| | A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice | Q34045099 |
| | Evaluation of a Burkholderia pseudomallei Outer Membrane Vesicle Vaccine in Nonhuman Primates | Q34081215 |
| | Mucosal immunity and vaccines | Q34409172 |
| | Mechanistic insight into the TH1-biased immune response to recombinant subunit vaccines delivered by probiotic bacteria-derived outer membrane vesicles | Q34576021 |
| | Cross-presentation of synthetic long peptides by human dendritic cells: a process dependent on ERAD component p97/VCP but Not sec61 and/or Derlin-1. | Q35108299 |
| | Expression, immunogenicity, histopathology, and potency of a mosquito-based malaria transmission-blocking recombinant vaccine. | Q35867612 |
| | Disruption of Plasmodium falciparum development by antibodies against a conserved mosquito midgut antigen | Q35941338 |
| | Lipopolysaccharide: an endotoxin or an exogenous hormone? | Q36291743 |
| | Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice | Q36670217 |
| | Single-dose microparticle delivery of a malaria transmission-blocking vaccine elicits a long-lasting functional antibody response. | Q36998403 |
| | Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation | Q37403767 |
| | Regulatory T cells as adjuvant target for enhancing the viral disease vaccine efficacy. | Q37468057 |
| | Antibodies to a single, conserved epitope in Anopheles APN1 inhibit universal transmission of Plasmodium falciparum and Plasmodium vivax malaria | Q37546481 |
| | Gram-negative outer membrane vesicles in vaccine development. | Q37906808 |
| | A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages | Q39520295 |
| | Efficient quantification and characterization of bacterial outer membrane derived nano-particles with flow cytometric analysis. | Q39592127 |
| | Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity | Q40232989 |
| | Mouse CMV infection delays antibody class switch upon an unrelated virus challenge. | Q42241208 |
| | Outer membrane vesicles of Neisseria lactamica as a potential mucosal adjuvant. | Q43441551 |
| | Plasmodium falciparum: membrane feeding assays and competition ELISAs for the measurement of transmission reduction in sera from Cameroon | Q44140956 |
| | Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants. | Q44755402 |
| | Altered primary CD8+ T cell response to a modified virus Ankara(MVA)-vectored vaccine in the absence of CD4+ T cell help | Q45423126 |
| | Epitope analysis of the malaria surface antigen pfs48/45 identifies a subdomain that elicits transmission blocking antibodies. | Q47829675 |
| | Immunological properties of recombinant proteins of the transmission blocking vaccine candidate, Pfs48/45, of the human malaria parasite Plasmodium falciparum produced in Escherichia coli. | Q47837358 |
| | Proinflammatory responses in the murine brain after intranasal delivery of cholera toxin: implications for the use of AB toxins as adjuvants in intranasal vaccines | Q48743601 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | cholera | Q12090 |
| | malaria transmission | Q56928847 |
| P304 | page(s) | 3576028 | |
| P577 | publication date | 2016-04-27 | |
| P1433 | published in | Journal of Immunology Research | Q26841936 |
| P1476 | title | Comparison of Intranasal Outer Membrane Vesicles with Cholera Toxin and Injected MF59C.1 as Adjuvants for Malaria Transmission Blocking Antigens AnAPN1 and Pfs48/45. | |
| P478 | volume | 2016 | |